Risks and limits of Mikrobiom Genetik

The question about risks and limits of microbiome genetics is valid, as many direct-to-consumer tests currently make exaggerated claims. MyBody-X does not offer genetic analysis of the microbiome in terms of host genes influencing gut flora. The provided context contains no specific information on this topic. In general, microbiome genetic tests (e.g., stool DNA analysis of bacterial composition) have several limitations. Results are heavily influenced by diet, medications, lifestyle, and probiotic use – a single stool sample is not a stable snapshot of the microbiome. Reference databases are often incomplete and biased toward Western populations. Clinically relevant, personalized action recommendations are usually not derivable. Many claimed associations between specific bacterial strains and diseases are not yet sufficiently supported by longitudinal studies. Furthermore, there are no standardized protocols for sample collection, storage, and analysis. The evidence is therefore rated as 'mixed': there are mechanistic hints, but no robust clinical validation for most consumer offerings. Consumers should be skeptical when far-reaching dietary or supplement recommendations are derived from a single test.